369 related articles for article (PubMed ID: 2684395)
1. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene.
Forgue-Lafitte ME; Coudray AM; Bréant B; Mester J
Cancer Res; 1989 Dec; 49(23):6566-71. PubMed ID: 2684395
[TBL] [Abstract][Full Text] [Related]
2. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of c-myc and transforming growth factor-alpha messenger RNA expression in poorly differentiated and well-differentiated colon carcinoma cells during the establishment of a quiescent state.
Mulder KM
Cancer Res; 1991 May; 51(9):2256-62. PubMed ID: 2015589
[TBL] [Abstract][Full Text] [Related]
4. Progressive relaxation of Go-arrest controls and altered responsiveness to insulin, EGF and thrombin in CCL39 lung fibroblasts over-expressing myc and ras oncogenes.
Pichon F; Seuwen K; Pouysségur J; Lagarde AE
Oncogene; 1988 Oct; 3(4):373-81. PubMed ID: 3078948
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts.
Trojanowska M; Wu LT; LeRoy EC
Oncogene; 1988 Oct; 3(4):477-81. PubMed ID: 3078955
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of transforming growth factor beta 1 on mitogenic response, transforming growth factor alpha, and c-myc in quiescent, well-differentiated colon carcinoma cells.
Mulder KM; Zhong Q; Choi HG; Humphrey LE; Brattain MG
Cancer Res; 1990 Dec; 50(23):7581-6. PubMed ID: 1701348
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor stimulates proliferation of human osteosarcoma cells and accumulation of c-myc messenger RNA.
Kirstein M; Baglioni C
J Cell Physiol; 1988 Mar; 134(3):479-84. PubMed ID: 2450880
[TBL] [Abstract][Full Text] [Related]
8. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents.
Futscher BW; Erickson LC
Cancer Res; 1990 Jan; 50(1):62-6. PubMed ID: 2104539
[TBL] [Abstract][Full Text] [Related]
9. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T
J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of c-myc in a transformed cell line approaching stationary phase growth in culture.
Mulder KM; Levine AE; Hinshaw XH
Cancer Res; 1989 May; 49(9):2320-6. PubMed ID: 2706619
[TBL] [Abstract][Full Text] [Related]
11. Efficient induction of focus formation in a subclone of NIH3T3 cells by c-myc and its inhibition by serum and by growth factors.
Blondel B; Talbot N; Merlo GR; Wychowski C; Yokozaki H; Valverius EM; Salomon DS; Bassin RH
Oncogene; 1990 Jun; 5(6):857-65. PubMed ID: 2193293
[TBL] [Abstract][Full Text] [Related]
12. Regulation of c-myc mRNA levels by insulin or platelet-poor plasma.
Gai XX; Rizzo MG; Valpreda S; Baserga R
Oncogene Res; 1989; 5(2):111-20. PubMed ID: 2691956
[TBL] [Abstract][Full Text] [Related]
13. Alterations in pim-1 and c-myc expression associated with sodium butyrate-induced growth factor dependency in autonomous rat Nb2 lymphoma cells.
Buckley AR; Leff MA; Buckley DJ; Magnuson NS; de Jong G; Gout PW
Cell Growth Differ; 1996 Dec; 7(12):1713-21. PubMed ID: 8959340
[TBL] [Abstract][Full Text] [Related]
14. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
15. Effects of interferon-beta on Daudi cells and on small cell lung carcinoma cells which over-express the c-myc oncogene.
Pape KA; Floyd-Smith G
Anticancer Res; 1989; 9(6):1737-42. PubMed ID: 2560625
[TBL] [Abstract][Full Text] [Related]
16. Coexpression of the c-kit and stem cell factor genes in breast carcinomas.
Hines SJ; Organ C; Kornstein MJ; Krystal GW
Cell Growth Differ; 1995 Jun; 6(6):769-79. PubMed ID: 7545433
[TBL] [Abstract][Full Text] [Related]
17. N-myc and c-src genes are differentially regulated in PCC7 embryonal carcinoma cells undergoing neuronal differentiation.
Sejersen T; Björklund H; Sümegi J; Ringertz NR
J Cell Physiol; 1986 May; 127(2):274-80. PubMed ID: 3700483
[TBL] [Abstract][Full Text] [Related]
18. Impaired carcinoembryonic antigen release during the process of suramin-induced differentiation of the human colonic adenocarcinoma cell clone HT29-D4.
Fantini J; Rognoni JB; Theveniau M; Pommier G; Marvaldi J
J Cell Physiol; 1990 Jun; 143(3):468-74. PubMed ID: 2162847
[TBL] [Abstract][Full Text] [Related]
19. Regulation of proliferation in a murine colony-stimulating factor-dependent myeloid cell line: superinduction of c-fos by the growth inhibitor 8-Br-cyclic adenosine 3':5' monophosphate.
Harel-Bellan A; Farrar WL
J Cell Biochem; 1988 Nov; 38(3):145-53. PubMed ID: 3068231
[TBL] [Abstract][Full Text] [Related]
20. Evidence for c-myc in the signaling pathway for TGF-beta in well-differentiated human colon carcinoma cells.
Mulder KM; Humphrey LE; Choi HG; Childress-Fields KE; Brattain MG
J Cell Physiol; 1990 Dec; 145(3):501-7. PubMed ID: 2273056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
